Product Images Simpesse

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Simpesse NDC 65862-864 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1. Percent of Women Taking Simpesse who Reported Unscheduled Bleeding and/or Spotting or only Unscheduled Bleeding - levonorethinyl fig1

Figure 1. Percent of Women Taking Simpesse who Reported Unscheduled Bleeding and/or Spotting or only Unscheduled Bleeding - levonorethinyl fig1

The figure shows the percentage of women taking Simpesse who reported unscheduled bleeding and/or spotting or only unscheduled bleeding. The percentage ranges from 80% to 0% on the Y-axis while the X-axis shows the duration of the cycle from days 1 to 364. Cycle 1 to Cycle 4 is shown with their respective duration sub-intervals. The data is collected from 758 women for Cycle 1, 625 women for Cycle 2, 533 women for Cycle 3, and 446 women for Cycle 4.*

Figure2 - levonorethinyl fig2

Figure2 - levonorethinyl fig2

This is a collection of results from various studies that compare the use of oral contraceptives containing ethynodiol diacetate (Ever GOC) and those containing norethindrone or levonorgestrel (Never COC). The studies mentioned are NICHD Women's Care Study, French EN cohort Study, Shanghai Women's Health Study, The Nurses Heath Sty I, Oxford Family Planning Study, and Darish Sex Hormone Regiser Stcy. The results are presented as odds ratios (OR), relative risks (RR), and hazard ratios (HR). The data seem to suggest that the risk of certain health outcomes may vary between the two types of contraceptives, but without further context or information, it is difficult to draw definitive conclusions.*

Figure 3 - levonorethinyl fig3

Figure 3 - levonorethinyl fig3

This text provides information on the different types of birth control methods and their effectiveness in preventing pregnancy, ranging from fewer than 1 pregnancy per 100 women in one year to 85 or more pregnancies per 100 women in one year. The text displays various birth control options such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patches, vaginal rings with hormones, condoms, diaphragm, spermicide, withdrawal, and no birth control.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.15 mg/0.03 mg and 0.01 mg (91 Tablets Pouch) - levonorethinyl fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.15 mg/0.03 mg and 0.01 mg (91 Tablets Pouch) - levonorethinyl fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.15 mg/0.03 mg and 0.01 mg (2 x 91 Tablets Carton) - levonorethinyl fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.15 mg/0.03 mg and 0.01 mg (2 x 91 Tablets Carton) - levonorethinyl fig5

This is a description of a contraceptive product called Simpesse. The NDC number and the constituents of the tablets are included. The product is intended to prevent pregnancy but does not protect against sexually transmitted diseases. The product comes in a pack of 91 tablets, including one extended cycle wallet containing 84 tablets and seven light blue tablets. The text also includes the manufacturer's name, address, and country of origin.*

levonorethinyl fig6

levonorethinyl fig6

Simpesse is a prescription medication containing levonorgestrel and ethinyl estradiol. It comes in two extended-cycle wallets, with each containing 91 tablets. The tablets are white and light blue, with the white ones containing 0.15 mg levonorgestrel USP and 0.03 mg ethinyl estradiol USP, while the light blue ones contain 0.01 mg ethinyl estradiol USP. This medication is used once daily for 91 consecutive days. It is child-resistant and should be kept out of reach of children. Simpesse does not protect against pregnancy or sexually transmitted diseases. The recommended storage temperature is from 20 to 25 degrees Celsius.*

Levonorgestrel Chemical Structure - levonorethinyl str1

Levonorgestrel Chemical Structure - levonorethinyl str1

Levonorgestrel is a chemical compound with the molecular formula CuHxO and MW of 3124. No further information is available to provide a more useful description.*

Ethinyl Estradiol Chemical Structure - levonorethinyl str2

Ethinyl Estradiol Chemical Structure - levonorethinyl str2

Ethinyl estradiol is a synthetic estrogen that is commonly used in combination with progestin as a component of hormonal contraceptives. The text seems to be providing information on its chemical formula and molecular weight, CuH:.0; MW:2964.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.